High-Intensity Focused Ultrasound (HIFU)

What is HIFU?

High-intensity focused ultrasound (HIFU) is a technique that uses heat to destroy the area of the prostate gland affected with cancer by means of a probe that gives out a beam of high-intensity focused ultrasound. 

Who is eligible for HIFU?

You may be eligible for HIFU treatment if:
1) You have a low-grade cancer (cancer which has not spread outside the prostate gland). 
2) You have recurrent prostate cancer after radiotherapy (known as salvage HIFU).
 
What are the advantages and disadvantages of HIFU treatment?

Deciding if HIFU treatment is right for you is a decision you should make after knowing the advantages and disadvantages and discussing them with your doctor. 
 
Advantages of HIFU Disadvantages of HIFU
Minimally invasive Scarring of the prostate
Minimal hospital stays Costly
Minimal side effects New treatment/not much data
  Appears to be less effective at controlling cancer
 
What are the possible complications of HIFU treatment?

As with any procedure, there are possible complications and side effects of HIFU treatment. Everyone responds differently to varying forms of treatment. Doctors have found that there is a slightly higher risk of some patients (3 to 4%) developing a fistula, which is an opening between the urinary system and the bowel. 

Is HIFU available in Canada?

HIFU is currently only offered in select centres in Canada, as it is still considered an experimental procedure. There is insufficient evidence to recommend HIFU as a routine treatment. 
 
HIFU is not covered by Canadian public health insurance – you will need to pay for the procedure yourself. 
 
Please visit the following sites to learn more about HIFU treatments in Canada.
 
 

For more information and support:


Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive